BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
HIV infection
,
Stem cell
,
Nosology
,
Fluoxetine
,
rs6983267
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mtor inhibitor
Summary
General Info
Curated Studies
Most Correlated Studies
Hepatocellular carcinomas treated with PI3K/mTOR inhibitors
Prostate cancer cells treated with mTOR inhibitors
Embryonic kidney HEK293T cells treated with mTOR-inhibitor PP242
Melanoma cell line treated with MEK and PI3K/mTOR inhibitors
Yeast BY4741 strain with RPH1 deletion treated with mTOR inhibitor rapamycin
Explore Curated Studies Results
Literature
Most Relevant Literature
An updated meta-analysis of effectiveness and safety of mTOR inhibitors in the management of tuberou…
CircPTEN suppresses human clear cell renal carcinoma progression and resistance to mTOR inhibitors b…
High-content analysis identified synergistic drug interactions between INK128, an mTOR inhibitor, an…
CRISPR screening identifies BET and mTOR inhibitor synergy in cholangiocarcinoma through serine glyc…
Calcineurin and mTOR inhibitors in kidney transplantation: integrative metamodeling on transplant su…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Using mTOR Inhibitors in the Prevention of BK Nephropathy
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid…
Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malf…
Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors
Identifying Mechanisms of Resistance to mTOR Inhibitors in Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ